Contact Celljevity
Whether you're a member of the global community, healthcare professional, or researcher, Celljevity offers assistance in the following areas
General Information on our Research:
We provide educational information about our ongoing research in cellular rejuvenation technology:
- The science and targeted indications
- The Prometheus Technology
- Scientific evidence and safety data
Research Information Request:
Email Contact:
info@celljevity.lifeCommon Questions Addressed:
Protocol Duration:
Approximately 12 weeks from initial consultation to cell delivery.
Indications Targeted:
Age-related conditions, autoimmune disorders, preventive longevity care.
Side Effects:
In 1,000+ patients, zero serious adverse events; minor side effects are rare.
Technology Note:
Prometheus technology is investigational, not FDA or EMA approved. Results vary; content is educational and not medical advice.
Medical Disclaimer: Celljevity's Prometheus technology is investigational and not FDA-approved. Research protocol options vary by jurisdiction. Individual results may vary. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent disease. Consult your healthcare provider.